Engineering naphthalimide-cyanine integrated near-infrared dye into ROS-responsive nanohybrids for tumor PDT/PTT/chemotherapy.
Journal:
Bioactive materials
Published Date:
Dec 20, 2021
Abstract
Photodynamic (PDT) and photothermal therapies (PTT) are emerging treatments for tumour ablation. Organic dyes such as porphyrin, chlorin, phthalocyanine, boron-dipyrromethene and cyanine are the clinically or preclinically used photosensitizer or photothermal agents. Development of structurally diverse near-infrared dyes with long absorption wavelength is of great significance for PDT and PTT. Herein, we report a novel near-infrared dye with naphthalimide modified cyanine skeleton. The introduction of naphthalimide moiety results in stronger electron delocalization and larger redshift in emission compared with . Furthermore, is co-loaded with chemotherapeutic drug into ROS-responsive mesoporous organosilica () to construct nanomedicine , which exhibits remarkable tumor inhibition effects through PDT/PTT/chemotherapy in vivo.
Authors
Keywords
No keywords available for this article.